1. Home
  2. COCP vs PT Comparison

COCP vs PT Comparison

Compare COCP & PT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • COCP
  • PT
  • Stock Information
  • Founded
  • COCP 2006
  • PT 2012
  • Country
  • COCP United States
  • PT China
  • Employees
  • COCP N/A
  • PT N/A
  • Industry
  • COCP Biotechnology: Pharmaceutical Preparations
  • PT Computer Software: Programming Data Processing
  • Sector
  • COCP Health Care
  • PT Technology
  • Exchange
  • COCP Nasdaq
  • PT Nasdaq
  • Market Cap
  • COCP 15.3M
  • PT 15.8M
  • IPO Year
  • COCP N/A
  • PT 2018
  • Fundamental
  • Price
  • COCP $1.52
  • PT $0.92
  • Analyst Decision
  • COCP Strong Buy
  • PT
  • Analyst Count
  • COCP 1
  • PT 0
  • Target Price
  • COCP $7.00
  • PT N/A
  • AVG Volume (30 Days)
  • COCP 12.6K
  • PT 18.2K
  • Earning Date
  • COCP 05-20-2025
  • PT 05-20-2025
  • Dividend Yield
  • COCP N/A
  • PT N/A
  • EPS Growth
  • COCP N/A
  • PT N/A
  • EPS
  • COCP N/A
  • PT N/A
  • Revenue
  • COCP N/A
  • PT $4,814,566.00
  • Revenue This Year
  • COCP N/A
  • PT N/A
  • Revenue Next Year
  • COCP N/A
  • PT N/A
  • P/E Ratio
  • COCP N/A
  • PT N/A
  • Revenue Growth
  • COCP N/A
  • PT N/A
  • 52 Week Low
  • COCP $1.12
  • PT $0.71
  • 52 Week High
  • COCP $3.26
  • PT $1.19
  • Technical
  • Relative Strength Index (RSI)
  • COCP 51.20
  • PT 39.45
  • Support Level
  • COCP $1.36
  • PT $0.87
  • Resistance Level
  • COCP $1.74
  • PT $1.00
  • Average True Range (ATR)
  • COCP 0.18
  • PT 0.05
  • MACD
  • COCP 0.01
  • PT -0.01
  • Stochastic Oscillator
  • COCP 50.00
  • PT 28.89

About COCP Cocrystal Pharma Inc.

Cocrystal Pharma Inc is a biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of influenza viruses, hepatitis C viruses, and noroviruses. It employs structure-based technologies and Nobel Prize-winning expertise to create first- and-in-class antiviral drugs. It is developing CC-31244, an investigational, oral, broad-spectrum replication inhibitor called a non-nucleoside inhibitor (NNI).

About PT Pintec Technology Holdings Limited

Pintec Technology Holdings Ltd is a technology platform that provides financial services in China in terms of loan volume facilitated. The company connects business partners and financial partners on its open platform and enables them to provide financial services to end-users. Its products include installment loans, personal loans, wealth management, insurance brokerage, SME loans, and others. The company generates its revenue from technical service fees also by providing financing for these borrowers and earn installment service fees, They earn wealth management services fees and commission on financial products.

Share on Social Networks: